DUBLIN, Nov. 17, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/jp3s7j/_world_flow) has announced the addition of the " World Flow Cytometry - Market Opportunities and Forecast, 2014 - 2022" report to their offering.
The flow cytometry market valued $3 billion in 2012 is further expected to reach $6.5 billion by 2020 growing at a CAGR of 30.9%
Increasing needs to enhance precisions and produce faster results as well as need for compact devices are compelling the clinical and diagnostic organization to adopt innovative technologies. Though popularity has been gained in the application field of life science industry, the cost of the instrument is impeding the growth. Due to this, many researchers are still reluctant in adopting this technology in their research work. Moreover, advancing technologies that has brought complex instrumentation requires highly skilled personals to operate these instruments. Flow cytometry market is in developing phase. Enhancing precision in results and presence of numerous flow cytometry techniques such as multicolor and multi-parameter flow cytometry has acted as a strong foothold, assisting the market growth in majority of the developed economies and foresees high potential in the emerging economies such as Asia Pacific and Africa. These economies have high demand for better health care techniques at an affordable cost. Increasing aged population who need better healthcare, increase in chronic disease and need for better diagnosis and treatment are few driving factors that are impacting the flow cytometry market state AMR analysts Debbie Shields and Rohini Patil.
The global market for flow cytometry is divided into segments such as products, technology, end users, and applications. Instruments market accounts for the largest share of revenue in the flow cytometry market at present and is expected to remain as the highest revenue generator in 2020. Increase in modularity, accessibility, incorporation of imaging capabilities, availability of wavelengths and targets and size reduction are few of the significant trends in the market assisting in adoption of the instruments by the end users. On the other hand, reagents market is expected to experience the highest growth rate of CAGR 12% during the analysis period. Primary reason escalating this segment is availability of several types of reagents that find diverse usability depending on specific applications like diagnostics, drug discovery, etc.
North America accounted for the largest share of revenue i.e. 43.5% of the overall Global flow cytometry market at $1.2 billion in 2011. The region is further expected to attain a market size of $2.8 billion by 2020 growing at a CAGR of 10.1%. The company profile in this includes: Advanced analytical Technologies, Inc., Merck Millipore, Becton, Dickinson & co, Beckman Coulter, eBioscience, Partech, Life technologies corp., Luminex Corp, Amnis Corp., Morphosys AG.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 World Flow Cytometry Market, By Component, 2014-2022
Chapter 5 World Flow Cytometry Market, By Technology, 2014-2022
Chapter 6 World Flow Cytometry Market, By Application, 2014-2022
Chapter 7 World Flow Cytometry Market, By End User, 2014-2022
Chapter 8 World Flow Cytometry Market, By Geography, 2014-2022
Chapter 9 Company Profiles
- Affymetrix Inc.
- Bio-Rad Laboratories
- Dako (Agilent Technologies)
- Danaher Corporation (Beckman Coulter)
- Dickinson and Co.
- Luminex Corporation
- Merck Millipore
- Miltenyi Biotec GmbH.
- Sysmex Corporation
- Thermo Fisher Scientific
For more information visit http://www.researchandmarkets.com/research/jp3s7j/_world_flow
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets